13 Property, plant and equipment
|
|
2022 |
||||||||
millions of CHF |
|
Land and buildings |
|
Machinery and technical equipment |
|
Other non-current assets |
|
Assets under construction |
|
Total |
Acquisition cost |
|
|
|
|
|
|
|
|
|
|
Balance as of January 1 |
|
68.9 |
|
218.6 |
|
17.1 |
|
22.6 |
|
327.1 |
Acquired through business combination |
|
– |
|
0.9 |
|
– |
|
– |
|
0.9 |
Deconsolidation of medmix Poland |
|
–0.3 |
|
–22.9 |
|
–0.4 |
|
–1.8 |
|
–25.3 |
Additions |
|
0.3 |
|
7.3 |
|
1.3 |
|
27.5 |
|
36.4 |
Disposals |
|
–1.0 |
|
–7.1 |
|
–1.2 |
|
– |
|
–9.3 |
Reclassifications |
|
2.3 |
|
12.9 |
|
1.5 |
|
–16.8 |
|
– |
Currency translation differences |
|
–2.2 |
|
–6.2 |
|
–0.6 |
|
–0.5 |
|
–9.5 |
Balance as of December 31 |
|
68.0 |
|
203.6 |
|
17.7 |
|
31.0 |
|
320.3 |
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation |
|
|
|
|
|
|
|
|
|
|
Balance as of January 1 |
|
24.6 |
|
131.4 |
|
7.1 |
|
0.6 |
|
163.7 |
Deconsolidation of medmix Poland |
|
–0.1 |
|
–12.2 |
|
1.9 |
|
– |
|
–10.4 |
Additions |
|
3.0 |
|
15.7 |
|
1.6 |
|
– |
|
20.3 |
Disposals |
|
–0.5 |
|
–6.0 |
|
–1.0 |
|
–0.6 |
|
–8.0 |
Impairments |
|
– |
|
1.5 |
|
0.0 |
|
– |
|
1.5 |
Currency translation differences |
|
–0.3 |
|
–3.8 |
|
–0.2 |
|
– |
|
–4.4 |
Balance as of December 31 |
|
26.7 |
|
126.6 |
|
9.3 |
|
– |
|
162.7 |
|
|
|
|
|
|
|
|
|
|
|
Net book value |
|
|
|
|
|
|
|
|
|
|
As of January 1 |
|
44.2 |
|
87.1 |
|
9.9 |
|
22.0 |
|
163.3 |
As of December 31 |
|
41.3 |
|
76.9 |
|
8.4 |
|
31.0 |
|
157.6 |
|
|
2021 |
||||||||
millions of CHF |
|
Land and buildings |
|
Machinery and technical equipment |
|
Other non-current assets |
|
Assets under construction |
|
Total |
Acquisition cost |
|
|
|
|
|
|
|
|
|
|
Balance as of January 1 |
|
44.9 |
|
204.0 |
|
16.3 |
|
45.7 |
|
310.8 |
Acquired through business combination |
|
– |
|
– |
|
– |
|
– |
|
– |
Additions |
|
2.8 |
|
8.6 |
|
1.2 |
|
17.2 |
|
29.8 |
Disposals |
|
–0.2 |
|
–4.5 |
|
–2.0 |
|
– |
|
–6.6 |
Reclassifications |
|
22.6 |
|
12.6 |
|
1.8 |
|
–37.0 |
|
– |
Currency translation differences |
|
–1.2 |
|
–2.2 |
|
–0.3 |
|
–3.3 |
|
–6.9 |
Balance as of December 31 |
|
68.9 |
|
218.6 |
|
17.1 |
|
22.6 |
|
327.1 |
|
|
|
|
|
|
|
|
|
|
|
Accumulated depreciation |
|
|
|
|
|
|
|
|
|
|
Balance as of January 1 |
|
23.5 |
|
118.8 |
|
7.5 |
|
– |
|
149.8 |
Additions |
|
2.7 |
|
17.4 |
|
1.5 |
|
– |
|
21.6 |
Disposals |
|
–0.2 |
|
–4.4 |
|
–1.9 |
|
– |
|
–6.5 |
Impairments |
|
– |
|
0.2 |
|
– |
|
0.6 |
|
0.8 |
Currency translation differences |
|
–1.4 |
|
–0.6 |
|
–0.0 |
|
– |
|
–1.9 |
Balance as of December 31 |
|
24.6 |
|
131.4 |
|
7.1 |
|
0.6 |
|
163.7 |
|
|
|
|
|
|
|
|
|
|
|
Net book value |
|
|
|
|
|
|
|
|
|
|
As of January 1 |
|
21.4 |
|
85.2 |
|
8.8 |
|
45.7 |
|
161.0 |
As of December 31 |
|
44.2 |
|
87.1 |
|
9.9 |
|
22.0 |
|
163.3 |
The group performed impairment tests on production machines and facilities, resulting in impairments of CHF 1.5 million as of December 31, 2022 (December 31, 2021: CHF 0.8 million), all of which were charged to other operating expenses.
In 2022, the group sold property, plant and equipment with a net book value of CHF 1.3 million for CHF 1.3 million, resulting in a net gain of CHF 0.0 million (2021: property, plant and equipment with a net book value of CHF 0.1 million sold for CHF 0.2 million, resulting in a net gain of CHF 0.1 million).